AstraZeneca: EMA says blood clots 'very rare' side effect

The European Medicines Agency says blood clotting should be listed as a 'very rare' side effect of the AstraZeneca coronavirus vaccine. But the EU regulator says the benefits of the jab outweigh the risks.